In the BioHarmony Drug Report Database

"Preview" Icon


Advil, Advil Liqui-gels, Advil Migraine Liqui-gels, Caldolor, Children’s Advil, Children’s Advil-flavored, Children’s Elixsure, Children’s Motrin, Ibu, Infant’s Advil, Junior Strength Advil, Junior Strength Motrin, Midol Liquid Gels, Motrin, Motrin Ib, Motrin Migraine Pain, Nuprin, Pediatric Advil, Rufen, Pedea (ibuprofen) is a small molecule pharmaceutical. Ibuprofen was first approved as Advil on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, dysmenorrhea, fever, and gout amongst others in the USA. It has been approved in Europe to treat patent ductus arteriosus. The pharmaceutical is active against prostaglandin G/H synthase 1 and prostaglandin G/H synthase 2. In addition, it is known to target sodium-coupled monocarboxylate transporter 1, acid-sensing ion channel 1, peroxisome proliferator-activated receptor gamma, and aldo-keto reductase family 1 member C2. Advil’s patents are valid until 2032-03-16 (FDA).


Trade Name



Common Name








ankylosing spondylitis, bursitis, dysmenorrhea, fever, gout, inflammation, juvenile arthritis, menorrhagia, osteoarthritis, patent ductus arteriosus, postoperative pain, premenstrual syndrome, rheumatoid arthritis

Drug Class


Anti-inflammatory/analgesic agents (ibuprofen type)

Image (chem structure or protein)

Ibuprofen structure rendering